102
Participants
Start Date
October 1, 2020
Primary Completion Date
October 1, 2022
Study Completion Date
October 1, 2023
LiDCO
"We plan to elucidate the pathophysiology and molecular subtypes of acute pancreatitis in order to develop specific biomarkers and identify new drug targets. The evaluation will include an analysis of the impact of obesity and the metabolic profile during the disease course of acute pancreatitis.~Supportive treatments will be registered including an assessment of the fluid balance based on the fluid intake and loss and weight. Bioimpedance will be assessed at admission/day1, day 2, day 3,"
Gastroenheden, Hvidovre Hospital, Hvidovre
Copenhagen University Hospital, Hvidovre
OTHER